A leading multinational pharmaceutical company had a doctor database that looked complete — but more than half of its records were outdated, duplicated, or missing key details. Medical reps were dialling wrong numbers, visiting old clinic addresses, and tailoring outreach around specialities that no longer matched. Using Multiplier AI’s GenAI Doctor Data Platform, the company cleaned and validated its entire HCP database, enriched every profile with real-time professional insights, and segmented doctors by speciality, interest, and prescribing behaviour — all under DPDP, UCPMP, GDPR, and HIPAA-aligned consent. Within two quarters, reps had doubled their face time with the right doctors and prescriptions had risen 25%.
On paper, the company’s CRM held tens of thousands of doctor records. In practice, that data had quietly become one of the commercial team’s biggest liabilities. An internal audit found that over 50% of doctor records were inaccurate, duplicated, or incomplete — wrong phone numbers, outdated clinic addresses, missing specialities, and no record of consent.
This is not unusual. Physician data is among the most volatile in any database: the American Medical Association reports that roughly 30% of physicians change their practice setting within five years, and identifiers shift every month as doctors relocate, switch hospitals, or update qualifications. A database cleaned once a year is already wrong.
The downstream cost was real:
- Wasted field effort — reps spent up to two-thirds of their visits chasing wrong or unreachable contacts. At an estimated $200–$500 per pharma sales call, inaccurate data burned budget on every cycle.
- Shrinking access — only ~44% of physicians are now “rep-accessible” (ZS AccessMonitor), down from nearly 80% in 2008, so a wasted meeting is a wasted opportunity.
- Generic outreach — without reliable data on each doctor’s speciality, interests, and preferred channel, communication stayed one-size-fits-all, weakening brand recall and prescription consideration.
- Compliance exposure — records carried no structured consent, a growing risk under DPDP, UCPMP, GDPR, and HIPAA.
Gartner estimates poor data quality costs the average organisation $12.9 million a year. For a field-force-driven pharma business, that shows up directly as lost selling time and missed prescriptions.
The company deployed Multiplier AI’s GenAI Doctor Data Platform — a privately deployed, healthcare-only AI system that connects directly to the existing CRM (compatible with Veeva and Salesforce) and turns a stale doctor database into a continuously maintained, gold-standard asset.
Delivery happened in four steps:
- Data cleansing & validation — AI agents de-duplicated, corrected, and verified every record against trusted sources, resolving the 50%+ discrepancy and creating one accurate profile per doctor.
- Real-time enrichment — each profile was enriched with live professional signals: speciality, sub-speciality, affiliations, awards, publications, and digital footprint across professional and social platforms — so reps walk in informed.
- Data-driven segmentation — doctors were segmented by speciality, clinical interest, prescribing behaviour, and channel preference, so the right message reaches the right HCP.
- Consent & compliance — every record was brought under structured, auditable consent aligned with DPDP and UCPMP (India) and GDPR and HIPAA (global), with human-in-the-loop governance and full audit trails.
Because the platform keeps validating and refreshing data continuously — not once a year — the CRM stays clean long after go-live. The same clean foundation now powers hyper-personalised HCP content and omnichannel doctor outreach on each doctor’s preferred channel.
Within 30–60 days of deployment, the clean, enriched, segmented database changed how the field force worked — and how doctors responded.
- 2× rep face time — with accurate contacts and pre-mapped routes, reps spent 100% more productive time in front of the right doctors instead of chasing bad data.
- 25% more prescriptions — sharper targeting and personalised, channel-right communication lifted prescription volume 25% in under two quarters.
- 90% lift in brand recall — relevant, well-timed interactions made the brand far more memorable at the moment of prescribing.
- 50%+ cleaner data — the discrepancy rate was resolved, and continuous validation keeps it that way.
- 50% gain in rep efficiency — reps reached the doctors that matter most for each therapy, cutting wasted calls and cost-per-prescription.
The data foundation didn’t just fix a database — it made every downstream investment in field force, content, and campaigns work harder.
The Hidden Cost of Dirty Doctor Data in Pharma
Most pharma CRMs don’t fail loudly. They decay quietly — a wrong number here, a moved clinic there — until reps spend more time correcting data than selling. Independent research puts the scale in perspective: physician records change constantly, only a minority of doctors are still freely rep-accessible, and poor data quality costs the average organisation $12.9 million a year. For this company, an audit revealed that fewer than half of its doctor records were fully accurate and usable.
What “Gold-Standard” Doctor Data Actually Looks Like
Clean data alone isn’t the goal. The gold standard is data that is accurate, enriched, segmented, consented, and continuously maintained. Multiplier AI’s GenAI Doctor Data Platform delivers all five: it verifies every doctor profile, layers on real-time professional and digital signals, segments HCPs by speciality and behaviour, manages consent under DPDP, UCPMP, GDPR, and HIPAA, and keeps the whole database fresh automatically. That is the difference between a list you bought once and a living asset your CRM can act on.
From Clean Data to Commercial Impact
Better data changes rep behaviour first, then business outcomes. With accurate contacts and pre-mapped territories, reps stopped chasing dead ends and started spending real time with the doctors who matter for each therapy.
Built for Compliance — DPDP, UCPMP, GDPR and HIPAA
In pharma, engagement and compliance are inseparable. Every doctor record in the platform carries structured, auditable consent, aligned with India’s DPDP Act and UCPMP 2024 and with global GDPR and HIPAA standards. Human-in-the-loop governance and full audit trails mean the commercial team can move fast without creating regulatory risk. See how Multiplier AI approaches DPDP-compliant HCP marketing.
Why Pharma Teams Choose Multiplier AI
Most platforms sell generic data or bolt an AI layer onto legacy systems and leave execution to your team. Multiplier AI is different: privately deployed AI agents, healthcare-only domain expertise, agents that run data operations end to end, and compliance built in from day one. Teams typically see baseline metrics, agent-driven improvements, and clear ROI within 30 to 60 days. Explore more AI solutions for pharma companies or browse other Multiplier AI case studies. This is not another tool — it is an operating layer for life sciences commercial execution.
“Once our doctor data was clean, our reps finally spent their time with the right doctors instead of chasing wrong numbers. The lift in prescriptions followed naturally.”
Doctor data decays fast — ~30% of physicians change practice settings within five years, so a CRM cleaned once a year is already out of date.
Bad data is expensive — at $200–$500 per sales call and shrinking rep access, every inaccurate record wastes selling time and budget.
Clean, enriched, segmented data is the multiplier — it doubled rep face time and lifted prescriptions 25%.
Compliance is built in, not bolted on — DPDP, UCPMP, GDPR, and HIPAA-aligned consent with full audit trails.
Ready to See Similar Results?
Talk to our team about your challenges. No pitch — just a real conversation about what you need.
Schedule a 30-Minute Free Consultation →Let's Discuss Your Requirements
